106 related articles for article (PubMed ID: 18839939)
1. Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenografts.
Eiseman JL; Bai L; Jung WH; Moura-Letts G; Day BW; Curran DP
J Med Chem; 2008 Nov; 51(21):6650-3. PubMed ID: 18839939
[TBL] [Abstract][Full Text] [Related]
2. A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos.
Vollmer LL; Jiménez M; Camarco DP; Zhu W; Daghestani HN; Balachandran R; Reese CE; Lazo JS; Hukriede NA; Curran DP; Day BW; Vogt A
Mol Cancer Ther; 2011 Jun; 10(6):994-1006. PubMed ID: 21490306
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis and biological evaluation of C16 analogs of (-)-dictyostatin.
Jung WH; Harrison C; Shin Y; Fournier JH; Balachandran R; Raccor BS; Sikorski RP; Vogt A; Curran DP; Day BW
J Med Chem; 2007 Jun; 50(13):2951-66. PubMed ID: 17542572
[TBL] [Abstract][Full Text] [Related]
4. Formal synthesis of dictyostatin and synthesis of two dictyostatin analogues.
Gallon J; Esteban J; Bouzbouz S; Campbell M; Reymond S; Cossy J
Chemistry; 2012 Sep; 18(37):11788-97. PubMed ID: 22865684
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 10,11-dihydrodictyostatin, a potent analogue of the marine anticancer agent dictyostatin.
Paterson I; Gardner NM; Poullennec KG; Wright AE
J Nat Prod; 2008 Mar; 71(3):364-9. PubMed ID: 18081257
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel analogues of dictyostatin.
Paterson I; Gardner NM; Poullennec KG; Wright AE
Bioorg Med Chem Lett; 2007 May; 17(9):2443-7. PubMed ID: 17336522
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
Paterson I; Gardner NM; Guzmán E; Wright AE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
[TBL] [Abstract][Full Text] [Related]
8. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis and biological evaluation of novel C2-C6 region analogues of dictyostatin.
Paterson I; Gardner NM; Guzmán E; Wright AE
Bioorg Med Chem; 2009 Mar; 17(6):2282-9. PubMed ID: 19022679
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor immunity against breast cancer induced by whole tumor cell vaccines genetically modified expressing α-Gal epitopes.
Xue D; Liang Y; Duan S; He J; Su J; Zhu J; Hu N; Liu J; Zhao Y; Lu X
Oncol Rep; 2016 Nov; 36(5):2843-2851. PubMed ID: 27666541
[TBL] [Abstract][Full Text] [Related]
11. Streamlined syntheses of (-)-dictyostatin, 16-desmethyl-25,26-dihydrodictyostatin, and 6-epi-16-desmethyl-25,26-dihydrodictyostatin.
Zhu W; Jiménez M; Jung WH; Camarco DP; Balachandran R; Vogt A; Day BW; Curran DP
J Am Chem Soc; 2010 Jul; 132(26):9175-87. PubMed ID: 20545347
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Sun Y; Wang X; Zhou Q; Lu Y; Zhang H; Chen Q; Zhao M; Su S
Oncol Rep; 2015 Jan; 33(1):338-46. PubMed ID: 25370743
[TBL] [Abstract][Full Text] [Related]
13. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
Al Safarjalani ON; Rais R; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of (-)-16-normethyldictyostatin: a potent analogue of (-)-dictyostatin.
Shin Y; Fournier JH; Balachandran R; Madiraju C; Raccor BS; Zhu G; Edler MC; Hamel E; Day BW; Curran DP
Org Lett; 2005 Jul; 7(14):2873-6. PubMed ID: 15987158
[TBL] [Abstract][Full Text] [Related]
15. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of potential antitumor agent, (-)-dictyostatin.
Ramachandran PV; Srivastava A; Hazra D
Org Lett; 2007 Jan; 9(1):157-60. PubMed ID: 17192109
[TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid.
Paterson I; Gardner NM
Chem Commun (Camb); 2007 Jan; (1):49-51. PubMed ID: 17279257
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice.
Guo CH; Hsia S; Hsiung DY; Chen PC
J Nutr Biochem; 2015 Dec; 26(12):1568-79. PubMed ID: 26344777
[TBL] [Abstract][Full Text] [Related]
20. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
